The death knell for academic led clinical trials in India?

• References

• 1 http://www.fairdrugs.org/uploads/files/Ethical_concerns_in_clinical_trials_in_India_An_investigation.pdf .
• 2 http://cdsco.nic.in/GSR%2053%28E%29%20dated%2030.01.2013.pdf .
• 3 http://cdsco.nic.in/GSR%2063%28E%29%20dated01%20.02.2013.pdf .
• 4 http://cdsco.nic.in/html/G.S.R%2072%28E%29%20dated%2008.02.2013.pdf .
• 5 http://cdsco.nic.in/Office%20Order%20dated%2019.11.2013.pdf .
• 6 Roberts I., Schierhout G., Alderson P.. Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review. J Neurol Neurosurg Psychiatr 1998; 65: 729-733
• 7 Ker K., Perel P., Blackhall K., Roberts I.. How effective are some common treatments for traumatic brain injury?. BMJ 2008; 337 7672 754-756
• 8 MRC-CRASH Trial Collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004; 364 9442 1321-1328
• 9 The CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. The Lancet 2010; 376 9734 23-32
• 10 Dewan Y, Komolafe EO, Mejia-Mantilla JH, Perel P, Roberts I, Shakur H, CRASH-3 Collaborators. CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012 Jun 21;13:87. http://dx.doi.org/10.1186/1745-6215-13-87 .
• 11 CRASH-2 Collaborators (Intracranial Bleeding Study). Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ 2011; 343
• 12 Yutthakasemsunt S., Kittiwatanagul W., Piyavechvirat P., Thinkamrop B., Phuenpathom N., Lumbiganon P.. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial. BMC Emerg Med 2013; Nov 22 13 (01) 20